EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Predictive Biomarkers for Immunotherapy in Gastric Cancer: Current Status and Emerging Prospects

Wanting Hou, Yaqin Zhao, Hong Zhu iD

International Journal of Molecular Sciences · 18.10.2023 · 24 (20) · 15321

DOI: 10.3390/ijms242015321 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 18.10.2023. Verfasst von Wanting Hou und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Abdominal Tumor Multimodality Treatment, Cancer Center, West China Hospital, Sichuan University, Chengdu 610065, China. Hauptthemen laut MEDLINE: Stomach Neoplasms, Epstein-Barr Virus Infections. Die Arbeit wurde bisher 92-mal zitiert (Crossref) und nennt 124 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the Natural Science Foundation of Sichuan Province, Natural Science Foundation of Sichuan Province, Post-Doctor Research Project, West China Hospital, Sichuan University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Gastric cancer presents substantial management challenges, and the advent of immunotherapy has ignited renewed hope among patients. Nevertheless, a significant proportion of patients do not respond to immunotherapy, and adverse events associated with immunotherapy also occur on occasion, underscoring the imperative to identify suitable candidates for treatment. Several biomarkers, including programmed death ligand-1 expression, tumor mutation burden, mismatch repair status, Epstein–Barr Virus infection, circulating tumor DNA, and tumor-infiltrating lymphocytes, have demonstrated potential in predicting the effectiveness of immunotherapy in gastric cancer. However, the quest for the optimal predictive biomarker for gastric cancer immunotherapy remains challenging, as each biomarker carries its own limitations. Recently, multi-omics technologies have emerged as promising platforms for discovering novel biomarkers that may help in selecting gastric cancer patients likely to respond to immunotherapy. The identification of reliable predictive biomarkers for immunotherapy in gastric cancer holds the promise of enhancing patient selection and improving treatment outcomes. In this review, we aim to provide an overview of clinically established biomarkers of immunotherapy in gastric cancer. Additionally, we introduce newly reported biomarkers based on multi-omics studies in the context of gastric cancer immunotherapy, thereby contributing to the ongoing efforts to refine patient stratification and treatment strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Stomach NeoplasmsEpstein-Barr Virus InfectionsHumansHerpesvirus 4, HumanImmunotherapyBiomarkers, TumorB7-H1 Antigen

Stichwörter der Autor:innen

gastric cancerimmune checkpoint inhibitorimmunotherapypredictive biomarker

Substanzen

Biomarkers, TumorB7-H1 Antigen

Autor:innen und Institutionen

  • Division of Abdominal Tumor Multimodality Treatment, Cancer Center, West China Hospital, Sichuan University, Chengdu 610065, China.
  • Department of Radiation Oncology, Cancer Center, West China Hospital, Sichuan University, Chengdu 610065, China.

ORCID-Profile: Hong Zhu

Förderung

  • the Natural Science Foundation of Sichuan Province
  • Natural Science Foundation of Sichuan Province
  • Post-Doctor Research Project, West China Hospital, Sichuan University

Zitieren

APA

Hou, W., Zhao, Y., & Zhu, H. (2023). Predictive Biomarkers for Immunotherapy in Gastric Cancer: Current Status and Emerging Prospects. International Journal of Molecular Sciences, 24(20), 15321. https://doi.org/10.3390/ijms242015321

Vancouver

Hou W, Zhao Y, Zhu H. Predictive Biomarkers for Immunotherapy in Gastric Cancer: Current Status and Emerging Prospects. International Journal of Molecular Sciences. 2023;24(20):15321. doi:10.3390/ijms242015321

BibTeX
@article{Hou2023,
  author = {Hou, Wanting and Zhao, Yaqin and Zhu, Hong},
  title = {Predictive Biomarkers for Immunotherapy in Gastric Cancer: Current Status and Emerging Prospects},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  volume = {24},
  number = {20},
  pages = {15321},
  doi = {10.3390/ijms242015321}
}
Kostenlos starten →